R
Respiri Ltd
ASX:RSH
Respiri Ltd
ASX:RSH
Price:
0.035
AUD
Market Closed
Market Cap:
AU$55.1m
Relative Value
The Relative Value of one RSH stock under the Base Case scenario is 0.003 AUD. Compared to the current market price of 0.035 AUD, Respiri Ltd is Overvalued by 91%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RSH
Relative Value
Base Case
0.003
AUD
Overvaluation 91%
R
Multiples Across Competitors
RSH Competitors Multiples
Respiri Ltd Competitors
Respiri Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
R
|
Respiri Ltd
ASX:RSH
|
55.1m AUD | 29.8 | -7.3 | -7.4 | -7.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.6B USD | 4.3 | 29.5 | 16.7 | 22.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.6B USD | 17.5 | 61.8 | 47.2 | 57.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
136.1B USD | 5.4 | 41.9 | 21.3 | 25.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.1B USD | 3.7 | 27.3 | 15.3 | 22.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.3B USD | 5.7 | 39.5 | 23.5 | 32 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.2B USD | 2.7 | 35 | 12.8 | 21.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.9B EUR | 2 | 21.6 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.3B USD | 11.9 | 48.3 | 34.6 | 38.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.6B USD | 7.6 | 32.6 | 23.1 | 25.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
40.1B USD | 7.4 | 27 | 19.1 | 21.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
